|Year : 2018 | Volume
| Issue : 1 | Page : 7-8
One-minute ophthalmology: Spend just a minute to challenge your skills
Carol Shields1, Fairooz P Manjandavida2
1 Wills Eye Institute, Walnut Street, Philadelphia 19107, PA, USA
2 HORUS Specialty Eye Care, and Prabha Eye Hospital and Research Centre, Bengaluru, India
|Date of Web Publication||28-Dec-2017|
Wills Eye Institute, Walnut Street, Philadelphia 19107, PA
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Shields C, Manjandavida FP. One-minute ophthalmology: Spend just a minute to challenge your skills. Indian J Ophthalmol 2018;66:7-8
|How to cite this URL:|
Shields C, Manjandavida FP. One-minute ophthalmology: Spend just a minute to challenge your skills. Indian J Ophthalmol [serial online] 2018 [cited 2020 Aug 14];66:7-8. Available from: http://www.ijo.in/text.asp?2018/66/1/7/221779
We would like to introduce to the readership an exciting new section in this issue of the Indian Journal of Ophthalmology, entitled “One Minute Ophthalmology.” This segment will be incorporated into each upcoming issue of the journal, designed to teach the reader an important point in approximately 1 minute using a problem-solving, case-based questions and discussion approach. It will instill critical thinking to solve a case with clinical reasoning and analysis. This section is designed to encourage the reader to think “What would I do in this case?” and then choose the most appropriate alternative. This promises to be stimulating, challenging, and instructive. We welcome the readership to consider submission of a case, common or rare, to this section at the journal website at <http://www.journalonweb.com/ijo>.
The goal of this new feature is to hone our clinical skills to be razor sharp.
One-minute ophthalmology (OMO), exactly as the name indicates, is to teach a valuable ophthalmic point in 1 minute. This new addition to the journal will be in a single page, concise case report format, and divided into short mini segments. These mini segments include word count-limited components so that the case fits neatly on one page as follows:
- Title – Clinical title without revealing the diagnosis
- Case – Description limited to ≤100 words
- What is your next step? – Listing four choices as A, B, C, and D and limited to ≤50 words
- Illustration – Limited to ≤4 images, preferably in neat montage arrangement, tiff format, 300 dots per inch
- Findings – Information regarding imaging, blood testing, histopathology, or others, limited to ≤100 words
- Diagnosis – Listed in ≤5 words
- Correct answer – Listed by the correct letter A, B, C, and D, as indicated in What is your next step?
- Discussion – Description of disease in ≤100 words
- References – Limited to ≤3
- Authors and affiliations – Limited to ≤3 authors. List affiliations.
We encourage you to take time to read the first OMO case in this issue of the Indian Journal of Ophthalmology. Challenge your skills. Solve the riddle. See if you would manage the patient as suggested by the authors.
Going forward, we welcome readers of the journal to think of their best-instructive case and submit to the journal at <http://www.journalonweb.com/ijo> for peer review. Together we spend just a minute, share an enlightening case, learn from each other, and polish our clinical acumen, to walk away with greater knowledge – as a more-clever ophthalmologist.
| Authors|| |
Dr. Carol Shields was trained in ophthalmology at Wills Eye Hospital in Philadelphia, USA and completed fellowship training in ocular oncology and ophthalmic pathology. She is currently Director of the Oncology Service, Wills Eye Hospital, and Professor of Ophthalmology at Thomas Jefferson University in Philadelphia, USA. Each year the Oncology Service manages approximately 500 patients with uveal melanoma, 120 patients with retinoblastoma, and numerous other intraocular, orbital, and adnexal tumors from the United States and abroad. Dr. Shields takes special interest in the management of retinoblastoma, uveal melanoma, as well as other intraocular tumors and conjunctival tumors. Dr Shields is a world authority in Ocular Oncology, and is a highly accomplished clinician, academician and a researcher; IJO is duly proud to have her on the Editorial Board and enthusiastically mentor the Journal.